Sammy Elmariah from Massachusetts General Hospital: Using Metabolomics to Predict Acute Kidney Injury After TAVR

As transcatheter aortic valve replacement or TAVR becomes more common, more work is being done to help patients undergoing this procedure.

Sammy Elmariah, MD, MPH, from Massachusetts General Hospital, is involved in this work using metabolomics to try and predict the likelihood of acute kidney injury in this patient population. While the science is still being developed, Elmariah said early indications are that this can be a valuable tool in the future, especially as TAVR moves from being used in only the most severe cases to the more moderate ones, as well.